ADVOCATE. CONNECT. INNOVATE.

Meet With…Novo Ventures

South San Francisco, CA

10/3/2017

10:30am - 1:00pm

Novo Ventures is structured as an evergreen fund with an annual total of $350M to invest in private and public life science companies in North America and Europe. Their team identifies opportunities by leveraging a local presence in leading global biotech hubs and typically co-invests with other life sciences funds as either a lead or co-lead investor.
Novo Ventures has a strong focus on pre-commercial therapeutics and commercial med-tech companies, with opportunistic investments in diagnostics and research tools. Their team of professionals in Boston, Copenhagen, London and San Francisco has an active portfolio of more than 50 companies and has invested in more than 140 companies since 2000.

For more information on Novo Ventures visit http://www.novo.dk/ventures/about

Peter Moldt, Ph.D., Partner and Kenneth Harrison, Ph.D., Senior Associate with Novo Ventures, will be in attendance to provide an overview presentation on Novo Ventures’ key areas of interest and venture investment philosophy. Novo Ventures will also be meeting 1-on-1 with select companies.

Click Here for More Information

Contact: Nikki Sarantinos
Contact Email: nsarant1@its.jnj.com

Event Address:

329 Oyster Point Blvd.
Floor 3
South San Francisco, CA
94080